Language:

Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology

Mayo Clinic proceedings, 2014-09, Vol.89 (9), p.1287-1306 [Peer Reviewed Journal]

Mayo Foundation for Medical Education and Research ;2014 Mayo Foundation for Medical Education and Research ;Copyright © 2014 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved. ;COPYRIGHT 2014 Elsevier, Inc. ;Copyright Mayo Foundation for Medical Education and Research Sep 2014 ;2014 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved. 2014 ;ISSN: 0025-6196 ;EISSN: 1942-5546 ;DOI: 10.1016/j.mayocp.2014.05.013 ;PMID: 25192616 ;CODEN: MACPAJ

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology
Author: Herrmann, Joerg, MD ; Lerman, Amir, MD ; Sandhu, Nicole P., MD, PhD ; Villarraga, Hector R., MD ; Mulvagh, Sharon L., MD ; Kohli, Manish, MD
Subjects: Antineoplastic Agents - adverse effects ; Cancer ; Cardiovascular diseases ; Care and treatment ; Diagnosis ; Heart Diseases - chemically induced ; Heart Diseases - complications ; Heart Diseases - diagnosis ; Heart Diseases - etiology ; Humans ; Internal Medicine ; Ionizing radiation ; Neoplasms - complications ; Neoplasms - therapy ; Patient outcomes ; Risk Assessment ; Risk factors
Is Part Of: Mayo Clinic proceedings, 2014-09, Vol.89 (9), p.1287-1306
Description: Abstract The care for patients with cancer has advanced greatly over the past decades. A combination of earlier cancer diagnosis and greater use of traditional and new systemic treatments has decreased cancer-related mortality. Effective cancer therapies, however, can result in short- and long-term comorbidities that can decrease the net clinical gain by affecting quality of life and survival. In particular, cardiovascular complications of cancer treatments can have a profound effect on the health of patients with cancer and are more common among those with recognized or unrecognized underlying cardiovascular diseases. A new discipline termed cardio-oncology has thus evolved to address the cardiovascular needs of patients with cancer and optimize their care in a multidisciplinary approach. This review provides a brief introduction and background on this emerging field and then focuses on its practical aspects including cardiovascular risk assessment and prevention before cancer treatment, cardiovascular surveillance and therapy during cancer treatment, and cardiovascular monitoring and management after cancer therapy. The content of this review is based on a literature search of PubMed between January 1, 1960, and February 1, 2014, using the search terms cancer , cardiomyopathy , cardiotoxicity , cardio-oncology , chemotherapy , heart failure , and radiation.
Publisher: England: Elsevier Inc
Language: English
Identifier: ISSN: 0025-6196
EISSN: 1942-5546
DOI: 10.1016/j.mayocp.2014.05.013
PMID: 25192616
CODEN: MACPAJ
Source: MEDLINE
ProQuest Central

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology

Searching Remote Databases, Please Wait